Log In
Print this Print this


Also known as: tolcapone

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionCatechol-O-methyl-transferase (COMT) inhibitor that inhibits breakdown of levodopa
Molecular Target Catechol-O-methyl-transferase (COMT)
Mechanism of ActionCatechol-O-methyl-transferase (COMT) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationParkinson's disease (PD)
Indication DetailsAdjunct therapy for Parkinson's disease (PD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today